{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:14:32Z","timestamp":1785406472374,"version":"3.56.0"},"reference-count":24,"publisher":"Academy of Medicine, Singapore","issue":"7","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Acad Med Singap"],"abstract":"<jats:p>Introduction: Paediatric sexual assault (SA) victims should be assessed for post-exposure prophylaxis (PEP) to mitigate the risk of sexually transmitted infections (STIs). We describe the clinical characteristics of children and young persons (CYPs) presenting with SA at KK Women\u2019s and Children\u2019s Hospital in Singapore, viral PEP (human immunodeficiency virus [HIV] and hepatitis B virus [HBV]) prescribing practices, and STI evaluation at follow-up.\n\nMethod: Medical records of CYPs \u226416 years who presented with SA between January 2022 and August 2023 were reviewed, including assault and assailant characteristics, baseline and follow-up STI screening, PEP prescription, adherence and follow-up attendance. CYPs with SA in the preceding 72 hours by HIV-positive or HIV-status unknown assailants with high-risk characteristics were eligible for HIV PEP.\n\nResults: We analysed 278 CYPs who made 292 SA visits. There were 40 (13.7%) CYPs eligible for HIV PEP, of whom 29 (82.9%) received it. Among those tested at baseline, 9% and 34.9% of CYPs tested positive for Chlamydia trachomatis and Gardnerella vaginalis, respectively. None tested positive for Neisseria gonorrhoeae, Trichomonas vaginalis, HIV, HBV or hepatitis C. Majority of CYPs tested were HBV non-immune (n=167, 67.6%); only 77 (46.1%) received the vaccine. Out of 27 CYPs eligible for HBV PEP with immunoglobulin, only 21 (77.7%) received immunoglobulin. A total of 37 CYPs received HIV PEP, including 8 who were retrospectively deemed ineligible. Only 10 (27%) completed the course. Overall, 153 (57.7%) CYPs attended follow-up, and none seroconverted for HIV or HBV.\n\nConclusion: We report suboptimal rates of HBV post-exposure vaccination, and low compliance to HIV PEP and follow-up among paediatric SA victims. Factors contributing to poor compliance should be examined to optimise care for this vulnerable population.<\/jats:p>","DOI":"10.47102\/annals-acadmedsg.202571","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T02:36:49Z","timestamp":1752201409000},"page":"410","source":"Crossref","is-referenced-by-count":1,"title":["Post-exposure prophylaxis and follow-up in children and young persons presenting with sexual assault"],"prefix":"10.47102","volume":"54","author":[{"given":"Sarah Hui Wen","family":"Yao","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0228w5t68","id-type":"ROR","asserted-by":"publisher"}],"name":"KK Women's and Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Nadua","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0228w5t68","id-type":"ROR","asserted-by":"publisher"}],"name":"KK Women's and Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia Yin","family":"Chong","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0228w5t68","id-type":"ROR","asserted-by":"publisher"}],"name":"KK Women's and Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh Cheng","family":"Thoon","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0228w5t68","id-type":"ROR","asserted-by":"publisher"}],"name":"KK Women's and Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee Fu","family":"Yung","sequence":"additional","affiliation":[{"name":"KK Women's and Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie Woon Hui","family":"Tan","sequence":"additional","affiliation":[{"name":"KK Women's and Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Qian","family":"Kam","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0228w5t68","id-type":"ROR","asserted-by":"publisher"}],"name":"KK Women's and Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wong","sequence":"additional","affiliation":[{"name":"KK Women's and Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliet","family":"Tan","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0228w5t68","id-type":"ROR","asserted-by":"publisher"}],"name":"KK Women's and Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Li","sequence":"additional","affiliation":[{"name":"KK Women's and Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"26165","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Neu N, Heffernan-Vacca S, Millery M, et al. Postexposure Prophylaxis for HIV in Children and Adolescents After Sexual Assault: A Prospective Observational Study in an Urban Medical Center. Sex Transm Dis 2007;34:65-8. DOI: 10.1097\/01.olq.0000225329.07765.d8","DOI":"10.1097\/01.olq.0000225329.07765.d8"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Lee MH, Ganapathy S, Low SM, et al. A review of child sexual abuse cases presenting to a paediatric emergency department. Ann Acad Med Singap 2021;50:527-35. DOI: 10.47102\/annals-acadmedsg.2021127","DOI":"10.47102\/annals-acadmedsg.2021127"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Girardet RG, Lemme S, Biason TA, et al. HIV post-exposure prophylaxis in children and adolescents presenting for reported sexual assault. Child Abuse Negl 2009;33:173-8. DOI: 10.1016\/j.chiabu.2008.05.010","DOI":"10.1016\/j.chiabu.2008.05.010"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Jones ME, Tully JM. Hepatitis B prophylaxis in adolescents who present for examination after alleged sexual assault. J Paediatr Child Health 2020;56:1178-84. DOI: 10.1111\/jpc.14860","DOI":"10.1111\/jpc.14860"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Du Mont J, Myhr TL, Husson H, et al. HIV Postexposure Prophylaxis Use Among Ontario Female Adolescent Sexual Assault Victims: A Prospective Analysis. Sex Transm Dis 2008;35:973-8. DOI: 10.1097\/OLQ.0b013e3181824f3c","DOI":"10.1097\/OLQ.0b013e3181824f3c"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Fajman N, Wright R. Use of antiretroviral HIV post-exposure prophylaxis in sexually abused children and adolescents treated in an inner-city pediatric emergency department. Child Abuse Negl 2006;30:919-27. DOI: 10.1016\/j.chiabu.2006.02.013","DOI":"10.1016\/j.chiabu.2006.02.013"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Crawford-Jakubiak JE, Alderman EM, Leventhal JM, et al. Care of the Adolescent After an Acute Sexual Assault. Pediatrics 2017;139:e20164243. DOI: 10.1542\/peds.2016-4243","DOI":"10.1542\/peds.2016-4243"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Kaplan DM, Moore JL, Hirway P, et al. A Comprehensive Pediatric Acute Sexual Assault Protocol. Pediatr Emerg Care 2021;37:62-9. DOI: 10.1097\/PEC.0000000000001652","DOI":"10.1097\/PEC.0000000000001652"},{"key":"ref8","unstructured":"Dominguez KL, Smith DK, Vasavi Thomas, et al. Updated Guidelines for Antiretroviral Post-Exposure Prophylaxis after Sexual, Injection Drug Use, or other Nonoccupational Exposure to HIV\u2014United States, 2016. 18 April 2016. https:\/\/stacks.cdc.gov\/view\/cdc\/38856. Accessed 8 April 2024."},{"key":"ref9","unstructured":"World Health Organization. Guidelines for HIV post-exposure prophylaxis. Geneva: Word Health Organization; 2024."},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Schremmer RD, Swanson D, Kraly K. Human Immunodeficiency Virus Postexposure Prophylaxis in Child and Adolescent Victims of Sexual Assault. Pediatr Emerg Care 2005;21:502-6. DOI: 10.1097\/01.pec.0000173347.53271.38","DOI":"10.1097\/01.pec.0000173347.53271.38"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Ang LW, Cutter J, James L, et al. Seroepidemiology of hepatitis B virus infection among adults in Singapore: A 12-year review. Vaccine 2013;32:103-10. DOI: 10.1016\/j.vaccine.2013.10.057","DOI":"10.1016\/j.vaccine.2013.10.057"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Ng Y, Chua LAV, Cui L, et al. Seroprevalence of vaccine-preventable diseases among children and adolescents in Singapore: Results from the National Paediatric Seroprevalence Survey 2018. Int J Infect Dis 2020;92:234-40. DOI: 10.1016\/j.ijid.2019.12.015","DOI":"10.1016\/j.ijid.2019.12.015"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Chaves SS, Groeger J, Helgenberger L, et al. Improved anamnestic response among adolescents boosted with a higher dose of the hepatitis B vaccine. Vaccine 2010;28:28604. DOI: 10.1016\/j.vaccine.2010.01.059","DOI":"10.1016\/j.vaccine.2010.01.059"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Rahnavardi M, Shahali S, Montazeri A, et al. Health care providers\u2019 responses to sexually abused children and adolescents: a systematic review. BMC Health Serv Res 2022;22:441. DOI: 10.1186\/s12913-022-07814-9","DOI":"10.1186\/s12913-022-07814-9"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Roland ME. Postexposure prophylaxis after sexual exposure to HIV. Curr Opin Infect Dis 2007;20:39-46. DOI: 10.1097\/QCO.0b013e328012c5e0","DOI":"10.1097\/QCO.0b013e328012c5e0"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Se\u00f1a AC, Hsu KK, Kellogg N, et al. Sexual Assault and Sexually Transmitted Infections in Adults, Adolescents, and Children. Clin Infect Dis 2015;61:S85664. DOI: 10.1093\/cid\/civ786","DOI":"10.1093\/cid\/civ786"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Casalino E, Bouzid D, Antoniol S, et al. Assessment of HIV-postexposure prophylaxis prescription quality after a training programme and assistance in decisions provided by a computer-based decision program: a cross-over study. Acta Clin Belg 2022;77:495-509. DOI: 10.1080\/17843286.2021.1892422","DOI":"10.1080\/17843286.2021.1892422"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Olshen E, Hsu K, Woods ER, et al. Use of Human Immunodeficiency Virus Postexposure Prophylaxis in Adolescent Sexual Assault Victims. Arch Pediatr Adolesc Med 2006;160:674. DOI: 10.1001\/archpedi.160.7.674","DOI":"10.1001\/archpedi.160.7.674"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Shubber Z, Ford N. Adherence to HIV post-exposure prophylaxis for children\/adolescents who have been sexually assaulted: A systematic review of barriers, enablers, and interventions. Child Abuse Negl 2021;116:104143. DOI: 10.1016\/j.chiabu.2019.104143","DOI":"10.1016\/j.chiabu.2019.104143"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Taddeo D, Egedy M, Frappier JY. Adherence to treatment in adolescents. Paediatr Child Health 2008;13:19-24. DOI: 10.1093\/pch\/13.1.19","DOI":"10.1093\/pch\/13.1.19"},{"key":"ref21","unstructured":"Ministry of Health, Singapore. Subsidies for drugs on the Medication Assistance Fund (MAF) List at Public Healthcare Institutions. 26 October 2024. https:\/\/www.moh.gov.sg\/managing-expenses\/schemes-and-subsidies\/subsidies-for-drugs-on-the-medication-assistance-fund-(maf)-list-at-public-healthcare-institutions. Accessed 13 May 2025."},{"key":"ref22","unstructured":"Ministry of Health, Singapore. Subsidies for drugs on the Standard Drug List (SDL) at Public Healthcare Institutions. 2 January 2025. https:\/\/www.moh.gov.sg\/managing-expenses\/schemes-and-subsidies\/subsidies-for-drugs-on-the-standard-drug-list-(sdl)-at-public-healthcare-institutions. Accessed 13 May 2025."},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Fagen J, Talarico R, Mercier O, et al. Using telemedicine and virtual healthcare to improve clinical follow-up for survivors of sexual assault and intimate partner violence: a 7-year investigation of emergency department cases. CJEM 2025;27:53-63. DOI: 10.1007\/s43678-024-00783-4","DOI":"10.1007\/s43678-024-00783-4"}],"container-title":["Annals of the Academy of Medicine Singapore"],"original-title":[],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T02:01:51Z","timestamp":1782784911000},"score":1,"resource":{"primary":{"URL":"https:\/\/annals.edu.sg\/post-exposure-prophylaxis-and-follow-up-in-children-and-young-persons-presenting-with-sexual-assault\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":24,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,18]]}},"URL":"https:\/\/doi.org\/10.47102\/annals-acadmedsg.202571","relation":{},"ISSN":["2972-4066"],"issn-type":[{"value":"2972-4066","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]}}}